Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. - Wikidata - awgldk - TriplyDB

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma.

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma.

http://www.wikidata.org/entity/Q35537338

about

Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors Update in asthma 2009 Emerging therapies for severe asthma Biomolecular markers in assessment and treatment of asthma Defining severe asthma - an approach to find new therapies Tailored therapy for severe asthma Monoclonal antibodies and other biologic agents in the treatment of asthma Strain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammation Macrophage TNF-α mediates parathion-induced airway hyperreactivity in guinea pigs Cellular crosstalk between airway epithelial and endothelial cells regulates barrier functions during exposure to double-stranded RNA Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma Highlights in asthma 2005.Effects of 7,8-dihydro-8-oxo-deoxyguanosine on antigen challenge in ovalbumin-sensitized mice may be mediated by suppression of Rac.Asthma that is unresponsive to usual care Airway wall expression of OX40/OX40L and interleukin-4 in asthma Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.Hypersensitivity of Vagal Pulmonary Afferents Induced by Tumor Necrosis Factor Alpha in Mice.Psychological factors in asthma The complex relationship between inflammation and lung function in severe asthma Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.Interleukin-1β mediates virus-induced m2 muscarinic receptor dysfunction and airway hyperreactivity.IFN-γ and TNF-α synergize to inhibit CTGF expression in human lung endothelial cells Alveolar macrophages play a key role in cockroach-induced allergic inflammation via TNF-α pathway.Nasal lavage VEGF and TNF-α levels during a natural cold predict asthma exacerbations.Recommendation for optimal management of severe refractory asthma.Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Does airway smooth muscle express an inflammatory phenotype in asthma?Cytokine/anti-cytokine therapy - novel treatments for asthma?EGF-induced bronchial epithelial cells drive neutrophil chemotactic and anti-apoptotic activity in asthma Dishing the dirt on asthma: What we can learn from poor hygiene.Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production New therapies and management strategies in the treatment of asthma: patient-focused developments.Role of TNFalpha in pulmonary pathophysiology.Role of TNF-α in virus-induced airway hyperresponsiveness and neuronal M₂ muscarinic receptor dysfunction.Pharmacotherapy of severe asthma Bronchial asthma and hypovitaminosis D in Saudi children.Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma Transforming growth factor beta enhances respiratory syncytial virus replication and tumor necrosis factor alpha induction in human epithelial cells.Drug development for severe asthma: what are the metrics?

P2860

Q24306707-8EFB8ED2-C099-45B4-9BA4-03ECBA5E47D6 Q24599763-02523067-E79A-4775-A138-859827AE0CFA Q26861260-C2B1EDED-713E-43C0-A868-D2F59FDBC7D1 Q26994979-8A0165F4-C783-4C7D-BBA5-2F51F8A0DA4C Q27001054-7C8EB69A-5899-4613-9C42-14DD7A373F5F Q27016035-5C4AD738-A54A-4349-9854-2033267F9086 Q28270037-116CA675-94CF-463B-83D1-350229759852 Q28393042-84F81F56-AD40-4606-B101-D933B9C137E4 Q28396903-06AB8A52-B3D0-43DF-BC64-02A81EF08B49 Q28917154-D7B8E4CA-9268-482A-BF4F-CCBA87657D51 Q30234766-885F9267-A43F-454A-91E5-4C06971C4D17 Q33240806-12804A0D-79A7-4F08-BB15-8AE85FD82B3A Q33569531-F43DC6FF-91B0-42DD-A521-97F5F2A890D3 Q33575466-AC42107F-BBE5-476C-AFA4-05F272F7D3AC Q33776845-485C8C29-EEAF-4687-BC91-11C88911ED04 Q33793577-8DC03751-776A-44AF-8764-38FFF2CB2801 Q33795087-0D9D806B-FD93-41A7-ADC1-2FF8D827EC37 Q33848593-7CCB4247-2C26-46BF-BE6C-3F674BDA0E27 Q34067165-A127EF2B-53BA-4FAF-980A-44F668893F51 Q34154042-960D8A1B-002C-46B1-BFC9-0EDBD4E1F28E Q34198210-D7091E34-03F1-4934-8D7C-78EFA4C98878 Q34305545-05657448-1D96-44D6-B69C-BD34259AAB64 Q34429022-4AF9F02B-6D10-491B-98CB-33D13FAF9F4D Q34456618-D2E7791D-66D2-4E05-A37E-87387D3EE5C5 Q34584541-F0840400-068D-4713-80FF-E7A7C4AE45F0 Q34620187-889015D3-87B7-4750-B60A-731F59C57B6D Q34625206-B2A9C348-3FD0-444B-87AC-2DDF91F005DC Q34903113-E312694B-6F45-463B-ACD5-E4A2CC175EE6 Q34903133-DDC0D39B-E21B-42CD-A53E-3D1C471BD214 Q34988445-2FB12655-DC0A-4B6B-844A-54891E5D03C4 Q34999496-ECA74881-E985-41D8-8DAF-EFD6C4695D6D Q35023969-7E503D75-D776-4E80-A021-84A01074306D Q35025262-C938C373-33FF-40B4-9A76-E27E716EF8FA Q35094582-8563F7FD-52AF-4180-984F-DCF62AB1BECB Q35287436-D7AA8355-BFEF-410D-8E50-E234838B443A Q35322603-EEA65DF2-3531-43FA-AF6E-42B3F14AF8C8 Q35555589-0EA55363-13EB-44DC-82F2-3192F9697050 Q35706650-AE5C8B0E-45AE-44BA-9477-4093EF2CD78E Q35784976-C6AE4CDD-8D7B-461A-BBA8-8A72AFA284B5 Q36058940-54AD67EA-4A1F-4F09-81AD-2F122F5F2F5B

P2860

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma.

http://www.wikidata.org/entity/Q35537338

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Tumour necrosis factor (TNFalp ...... rticosteroid dependent asthma.

@ast

Tumour necrosis factor (TNFalp ...... rticosteroid dependent asthma.

@en

type

label

Tumour necrosis factor (TNFalp ...... rticosteroid dependent asthma.

@ast

Tumour necrosis factor (TNFalp ...... rticosteroid dependent asthma.

@en

prefLabel

Tumour necrosis factor (TNFalp ...... rticosteroid dependent asthma.

@ast

Tumour necrosis factor (TNFalp ...... rticosteroid dependent asthma.

@en

P1433

Q35537338-9984EB61-D986-4EDF-9C67-90B5C20BEC5D

P1476

Q35537338-CABD40A2-04A3-460C-A063-C73FD3411F12

P2093

Q35537338-0FAC69BE-896E-4D9D-8598-745ABC1A3775

Q35537338-4815FA82-7963-4711-887B-0B6E26615B72

Q35537338-505B7443-944E-405A-8004-56AB7997C1B9

Q35537338-5B53A729-8076-4B08-92FF-61E23DA48D1B

Q35537338-5B597DDF-421E-4001-84FE-0E14577642F3

Q35537338-92AFA600-40D9-404F-93DB-AD6EA883F0C2

Q35537338-9FB8872A-638F-4B2E-A5B9-9934655DC864

Q35537338-A50BE362-8456-420A-BB7D-5C6FDCDAF0CE

Q35537338-CD4CCF07-A7F2-47F9-8D67-2BD3E31911EA

Q35537338-D68AF4AF-6EA4-4965-90C5-B65A4E4ECBB3

P2860

Q35537338-09226C38-FE67-4C28-A727-6FF6B3655F06

Q35537338-0DFC2863-A9A6-4742-A066-2DCB43717487

Q35537338-0FFB32C9-F6E4-4193-8C1C-DA82EE1DE943

Q35537338-1E12C972-310A-4C2C-962F-2BE378462A93

Q35537338-2A16642A-DF91-4EE9-831C-655CC8D7C465

Q35537338-39320FD5-5568-4624-A508-F97693024E95

Q35537338-3E95747F-E305-4D59-950D-949F9306904F

Q35537338-51946B25-C027-4805-9FF0-ED6759759757

Q35537338-59D85C30-2D4A-40A8-95EF-0392FA55C002

Q35537338-788D20FA-550A-477F-8AC3-91B53F8FC977

P304

Q35537338-576CC39E-18B2-4584-BE27-4C30298A5234

P31

Q35537338-4CD15361-CE48-4BBB-A6A5-92C0E27DD354

P356

Q35537338-AEB38140-805B-4D94-8BE8-362DA0D954DA

P407

Q35537338-8180E4A6-1B60-4754-A7F3-CCACD2832E35

P433

Q35537338-9334D28E-3A7F-43F3-8C95-7FD9189DE883

P478

Q35537338-650733F8-28CE-42BB-933D-5FB80A5699F7

P50

Q35537338-5F039BA6-8529-4062-AE3F-8447F030FFD1

P577

Q35537338-58F05C4F-4648-4032-B307-3742FAC013E9

P5875

Q35537338-523486B8-51E8-4793-8DB9-A079A2CB6034

P698

Q35537338-95259D38-2B89-4EB0-BC43-A42244B51E5B

P921

Q35537338-4D154074-DA2A-487D-97E2-E20619D597AA

Q35537338-7d9be1e9-ec02-412d-a55b-635fd6ceeb2d

P932

Q35537338-F82F2EC2-772F-4808-B5A3-86D0D5174D83

P356

THX.2005.045260

P1433

P1476

Tumour necrosis factor (TNFalp ...... rticosteroid dependent asthma.

@en

P2093

Al Ali M

http://www.w3.org/2001/XMLSchema#string

Arshad HS

http://www.w3.org/2001/XMLSchema#string

Babu KS

http://www.w3.org/2001/XMLSchema#string

Beckett P

http://www.w3.org/2001/XMLSchema#string

Buckley M

http://www.w3.org/2001/XMLSchema#string

Chauhan A

http://www.w3.org/2001/XMLSchema#string

Davies DE

http://www.w3.org/2001/XMLSchema#string

Howarth PH

http://www.w3.org/2001/XMLSchema#string

Lau L

http://www.w3.org/2001/XMLSchema#string

McConnell W

http://www.w3.org/2001/XMLSchema#string

P2860

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Allergy and allergic diseases. First of two parts.

Pathophysiology of severe asthma.

Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma.

Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000.

Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease.

P304

1012-1018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2005.045260

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Stephen T. Holgate

P577

2005-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7597268

http://www.w3.org/2001/XMLSchema#string

P698

16166100

http://www.w3.org/2001/XMLSchema#string

P921

P932

1747263

http://www.w3.org/2001/XMLSchema#string